Cairn Investment Group, Inc. Abb Vie Inc. Transaction History

Cairn Investment Group, Inc.

  • $181 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 11, 2023
BUY
$138.31 - $165.87 $47,855 - $57,391
346 Added 16.2%
2,482 $401,000
Q3 2022

Oct 13, 2022
SELL
$134.21 - $153.93 $34,760 - $39,867
-259 Reduced 10.81%
2,136 $287,000
Q2 2022

Jul 28, 2022
BUY
$137.62 - $174.96 $329,599 - $419,029
2,395 New
2,395 $367,000

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cairn Investment Group, Inc. Portfolio

Follow Cairn Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cairn Investment Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email